Skip to main content
. 2018 Jan 1;28(1):60–67. doi: 10.1089/thy.2017.0059

Table 4.

Clinical Characteristics of 12 Papillary Thyroid Carcinomas Positive for RET/PTC

Histopathology Size, cm TNM Sex Age, years RET fusion gene
PTC, classical variant 2.6 pT3N1aM1 Female 9 PTC1 (CCDC6)
PTC, classical variant 0.9 pT1aN1aM0 Female 12 PTC3 (NCOA4)
PTC, classical variant 2.8 pT2N1aM0 Female 17 PTC1 (CCDC6)
PTC, classical variant 3.2 pT2N1aM1 Female 17 PTC1 (CCDC6)
PTC, classical variant 1.9 pT1bN1bM0 Male 18 PTC1 (CCDC6)
PTC, diffuse sclerosing variant Infa pT?N1bMx Female 5 PTC1 (CCDC6)
PTC, diffuse sclerosing variant 2.2 pT3N1bM0 Female 12 PTC1 (CCDC6)
PTC, diffuse sclerosing variant 5.6 pT3N1bM1 Female 13 PTC1 (CCDC6)
PTC, diffuse sclerosing variant 1.1 pT1bN1aM0 Female 16 PTC1 (CCDC6)
PTC, follicular variant, widely invasive Infa pT4aN1bMx Female 11 PTC1 (CCDC6)
PTC, follicular variant, widely invasive 5 pT3N1bM0 Female 13 PTC1 (CCDC6)
PTC, mix classical, solid, follicular Infa pTxN1bM0 Male 4 PTC3 (NCOA4)
a

Infiltrative form of papillary thyroid carcinomas (PTC) limiting the ability and value of reporting the tumor size.